🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of CLI-06657AA1-04 (formerly PB-102-F60) was to evaluate the ...
Status
Completed
Location
UAB Medicine
Start Date
2018-09-16
Trial ID
NCT03566017
Treatments Being Tested
The objective of CLI-06657AA1-03 (formerly PB-102-F51) is to evaluate the l...
Status
Completed
Location
UAB Medicine
Start Date
2018-11-13
Trial ID
NCT03614234
Treatments Being Tested
The objective of this treatment protocol is to provide guidance to Treating...
Status
Approved For Marketing
Location
University of Alabama-Birmingham
Start Date
TBD
Trial ID
NCT04552691
Treatments Being Tested
To evaluate the ongoing safety, tolerability, and efficacy parameters of PR...
Status
Completed
Location
University of Florida
Start Date
2014-01-16
Trial ID
NCT01981720
Treatments Being Tested
Pegunigalsidase alfa (PRX-102) is a long-term enzyme replacement therapy de...
Status
Completed
Location
#02
Start Date
2022-01-26
Trial ID
NCT05186324
Treatments Being Tested
A multi-centre, multi-country, observational, non-interventional, retrospec...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2024-11-06
Trial ID
NCT06663358
Treatments Being Tested
Pegunigalsidase-alfa may represent an advance in ERT for FD, based on its u...
Status
Active Not Recruiting
Location
Fabry disease center Berlin - Charité - Universitätsmedizin Berlin
Start Date
2023-10-01
Trial ID
NCT06095713
Treatments Being Tested
This was a randomized, double-blind, active control study of the enzyme rep...
Status
Completed
Location
UAB Medicine
Start Date
2016-06
Trial ID
NCT02795676
Treatments Being Tested
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in ...
Status
Recruiting
Location
Phoenix Children's
Start Date
2025-07-29
Trial ID
NCT06328608
Treatments Being Tested
The goal of this observational registry is to evaluate the safety and outco...
Status
Recruiting
Location
No physical study sites - Decentralized, web-based registry
Start Date
2025-05-23
Trial ID
NCT06941025
Treatments Being Tested